1. Home
  2. MDRR vs COCP Comparison

MDRR vs COCP Comparison

Compare MDRR & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDRR

Medalist Diversified REIT Inc.

HOLD

Current Price

$11.31

Market Cap

16.3M

Sector

Real Estate

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$1.50

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDRR
COCP
Founded
2015
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3M
15.6M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
MDRR
COCP
Price
$11.31
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
2.0K
4.2M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
2.39%
N/A
EPS Growth
N/A
54.65
EPS
N/A
N/A
Revenue
N/A
$12,712,091.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.55
$0.86
52 Week High
$14.52
$2.19

Technical Indicators

Market Signals
Indicator
MDRR
COCP
Relative Strength Index (RSI) 47.34 75.79
Support Level $11.00 $0.95
Resistance Level $12.49 $1.95
Average True Range (ATR) 0.24 0.12
MACD 0.02 0.05
Stochastic Oscillator 17.95 46.61

Price Performance

Historical Comparison
MDRR
COCP

About MDRR Medalist Diversified REIT Inc.

Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: